Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the ClinicFunding will accelerate preclinical validation of biofabricated tissue implants for soft tissue repair, wound healing and trauma care - while building the biological and manufacturing foundations for 3D-bioprinted viable human organs.
